Development of a novel optimized breathhold technique for myocardial T2 measurement in thalassemia

To develop a reproducible fast spin‐echo (FSE) technique for accurate myocardial T2 measurement with application to iron overload assessment in thalassemia.

[1]  J C Gore,et al.  An estimation and correction scheme for system imperfections in multiple‐echo magnetic resonance imaging , 1987, Magnetic resonance in medicine.

[2]  A. Piga,et al.  SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR , 1989, The Lancet.

[3]  A. Hoffbrand,et al.  High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. , 1990, Acta haematologica.

[4]  J. Gomori,et al.  Hepatic iron overload: quantitative MR imaging. , 1991, Radiology.

[5]  R W Parkey,et al.  Fast short-tau inversion-recovery MR imaging. , 1991, Radiology.

[6]  D. Halperin,et al.  Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. , 1993, Chest.

[7]  J. H. MacMillan,et al.  Survival in Medically Treated Patients with Homozygous β-Thalassemia , 1994 .

[8]  J. H. MacMillan,et al.  Survival in medically treated patients with homozygous beta-thalassemia. , 1994, The New England journal of medicine.

[9]  S J Graham,et al.  MR measurement of relative water content and multicomponent T2 relaxation in human breast , 1996, Magnetic resonance in medicine.

[10]  M. Bronskill,et al.  Criteria for analysis of multicomponent tissue T2 relaxation data , 1996, Magnetic resonance in medicine.

[11]  O. Simonetti,et al.  "Black blood" T2-weighted inversion-recovery MR imaging of the heart. , 1996, Radiology.

[12]  Corrected equations for susceptibility-induced T2-shortening. , 1999, Journal of magnetic resonance.

[13]  Matthew Darlison,et al.  Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register , 2000, The Lancet.

[14]  Nickolas Papanikolaou,et al.  Non-invasive myocardial iron assessment in thalassaemic patients. T2 relaxometry and magnetization transfer ratio measurements. , 2000, Acta radiologica.

[15]  J. Porter,et al.  Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk β-thalassemia , 2000 .

[16]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[17]  D. Pennell,et al.  Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia , 2002, The Lancet.

[18]  D. Pennell,et al.  A single breath‐hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload , 2003, Journal of magnetic resonance imaging : JMRI.

[19]  Mark A Westwood,et al.  Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia , 2003, Journal of magnetic resonance imaging : JMRI.

[20]  G. Brittenham,et al.  Noninvasive measurement of iron: report of an NIDDK workshop. , 2003, Blood.

[21]  L. Vlahos,et al.  Myocardial iron deposition in β-Thalassemia studied by magnetic resonance imaging , 1998, The International Journal of Cardiac Imaging.

[22]  T. S. St. Pierre,et al.  Single spin‐echo proton transverse relaxometry of iron‐loaded liver , 2004, NMR in biomedicine.

[23]  Mark A Westwood,et al.  Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. , 2006, Blood.

[24]  D. Firmin,et al.  Improved turbo spin‐echo imaging of the heart with motion‐tracking , 2006, Journal of magnetic resonance imaging : JMRI.

[25]  E. Vretou,et al.  T2 relaxation time study of iron overload in b-thalassemia , 1998, Magnetic Resonance Materials in Physics, Biology and Medicine.